Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Diversified Trust Co boosts PROCEPT BioRobotics stake, despite company's financial challenges and growth.
Diversified Trust Co increased its stake in PROCEPT BioRobotics by 54.6%, now owning 7,187 shares valued at $419,000.
PROCEPT, focused on surgical robotics for urology, especially for treating BPH, saw a 55.5% revenue growth but reported negative return on equity and net margin.
Analysts, however, have set an average target price of $90 per share with a ‘Moderate Buy’ recommendation, despite the financial challenges.
2 Articles
Diversified Trust Co aumenta la participación en PROCEPT BioRobotics, a pesar de los desafíos financieros y el crecimiento de la empresa.